Log in

300204 Staidson (Beijing) Biopharmaceuticals Co. Ltd. SZSE · China

Staidson (Beijing) Biopharmaceuticals Co. (300204) news

Staidson (Beijing) Biopharmaceuticals Co. Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 300204, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Staidson (Beijing) Biopharmaceuticals Co. news

We have not published a story on Staidson (Beijing) Biopharmaceuticals Co. yet. When there is news, it will appear here.

Questions about Staidson (Beijing) Biopharmaceuticals Co.

What is the ticker symbol of Staidson (Beijing) Biopharmaceuticals Co.?

Staidson (Beijing) Biopharmaceuticals Co. Ltd. trades under the ticker 300204 on SZSE.

Where is Staidson (Beijing) Biopharmaceuticals Co. listed?

Staidson (Beijing) Biopharmaceuticals Co. Ltd. is listed on SZSE.

Which country or territory is Staidson (Beijing) Biopharmaceuticals Co. listed under?

Our directory records Staidson (Beijing) Biopharmaceuticals Co. Ltd. under China.

What does Staidson (Beijing) Biopharmaceuticals Co. do?

Our directory classifies Staidson (Beijing) Biopharmaceuticals Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Staidson (Beijing) Biopharmaceuticals Co.?

The ISIN recorded for Staidson (Beijing) Biopharmaceuticals Co. Ltd. is CNE100001237.

Does aibio.space cover Staidson (Beijing) Biopharmaceuticals Co.?

aibio.space lists Staidson (Beijing) Biopharmaceuticals Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Staidson (Beijing) Biopharmaceuticals Co.?

Companies in our directory listed in the same country and business area as Staidson (Beijing) Biopharmaceuticals Co.: Beijing Science Sun Pharmaceutical Co., Guangzhou Baiyunshan Pharmaceutical Holdings Company, Mabwell (Shanghai) Bioscience Co., Anhui Anke Biotechnology (Group) Co., Shanghai Bao Pharmaceuticals Co, Pharmaron Beijing Co..

Investor discussion: Staidson (Beijing) Biopharmaceuticals Co.

Members talk about Staidson (Beijing) Biopharmaceuticals Co. (300204). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:300204 on TradingView.

Listing details

Staidson (Beijing) Biopharmaceuticals Co. Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 300204, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Staidson (Beijing) Biopharmaceuticals Co. Ltd.
Ticker
300204
Listing
SZSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE100001237
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.